Abstract
We prospectively evaluated autonomic function in 50 patients with clinical and manometric features of a neuropathic form of chronic intestinal pseudo-obstruction (CIP). In 26 patients, there were underlying disease processes that may have affected extrinsic neural control to viscera: diabetes mellitus (n = 16), previous gastric surgery (n = 5), and other neurologic disorders (n = 5). Our aim was to characterize autonomic function in these patients, and those 24 with CIP unassociated with a known underlying neurologic disorder (idiopathic group). We assessed vagal function and sympathetic cholinergic and adrenergic function by means of standardized autonomic tests and quantitated postprandial antral pressure activity. We also measured postprandial levels of pancreatic polypeptide and neurotensin as indicators of vagal function and of the delivery of nutrients to the distal small bowel. Among the idiopathic group (n = 24), two had evidence of a generalized sympathetic neuropathy and five abdominal vagal dysfunction (one had both). Among diabetic patients, three had sympathetic adrenergic failure, six had orthostasis with normal plasma noradrenaline, ten had signs of generalized sympathetic neuropathy and eight had abdominal vagal dysfunction. Vagal dysfunction was identified in all three patients who underwent vagotomy as part of their previous gastric survery. In the other neurologic syndromes, vagal function was abnormal in three of the five patients. Thus, autonomic and, particularly, vagal dysfunction are confirmed in a majority of patients with CIP associated with known diabetes or neurologic disorders; however, a previously unrecognized autonomic (chiefly vagal) neuropathy of undetermined cause has been identified in five of the 24 ‘idiopathic’ CIP patients. Autonomic function should be evaluated in patients presenting with the syndrome of chronic intestinal pseudo-obstruction.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Faulk DL, Anuras S, Christensen J. Chronic intestinal pseudoobstruction.Gastroenterology, 1978;74: 922–931.
Shuffler MD, Rohrmann CA, Chaffee RG, Brand DL, Delaney JH, Young JH. Chronic intestinal pseudo-obstruction: a report of 27 cases and review of the literature.Medicine 1981;60: 173–196.
Schuffler MD. Chronic intestinal pseudo-obstruction syndromes.Med Clin North Am 1981;65: 1331–1358.
Roman C, Gonella J. Extrinsic control of digestive tract motility. In: Johnson LR, Christensen J, Jackson MJ, Jacobson ED, Walsh JH, eds.Physiology of the Gastrointestinal Tract. Second edition. Vol. 1. New York: Raven Press, 1987: 507–553.
Camilleri M. Disorders of gastrointestinal motility in neurologic diseases.Mayo Clin Proc 1990;65: 825–846.
Krishnamurthy S, Schuffler MD. Pathology of neuromuscular disorders of the small intestine and colon.Gastroenterology 1987;93: 610–639.
Camilleri M, Fealey RD. Idiopathic autonomic denervation in eight patients presenting with functional gastrointestinal disease: a causal association?Dig Dis Sci 1990;35: 609–616.
Sodhi N, Camilleri M, Camoriano JK, Low PA, Fealey RD, Perry MC. Autonomic function and motility in intestinal pseudoobstruction caused by paraneoplastic syndrome.Dig Dis Sci 1989;34: 1937–1942.
Vassallo M, Camilleri M, Caron BL, Low PA. Gastrointestinal motor dysfunction in acquired selective cholinergic dysautonomia associated with infectious mononucleosis.Gastroenterology 1991;100: 252–258.
Bharucha AE, Camilleri M, Low PA, Zinsmeister AR. Autonomic dysfunction in gastrointestinal motility disorders.Gut 1993;34: 397–401.
Colemont LJ, Camilleri M. Chronic intestinal pseudoobstruction: diagnosis and treatment.Mayo Clin Proc 1989;64: 60–70.
Stanghellini V, Camilleri M, Malagelada J-R. Chronic idopathic intestinal pseudo-obstruction: clinical and intestinal manometric findings.Gut 1987;28: 5–12.
Jiang N-S, Machicek D. Measurement of catecholamines by liquid chromatography with amperometric detection. In: H. Parvez, ed.Progress in HPLC. Utrecht, The Netherlands: VNU Science Press, 1987: 395–424.
Low PA. Quantitation of autonomic responses. In: Dyck PJ, Thomas PK, Lambert EH, Bunge R, eds.Peripheral Neuropathy. Philadelphia, PA: WB Saunders Company, 1984: 1139–1165.
Christensen NJ. The biochemical assessment of sympathoadrenal activity in man.Clin Auton Res 1991;1: 167–172.
Buysschaert M, Donckier J, Dive A, Ketelslegers J-M, Lambert AE. Gastric acid and pancreatic polypeptide responses to sham feeding are impaired in diabetic subjects with autonomic neuropathy.Diabetes 1985;34: 1181–1185.
Greydanus MP, Vassallo M, Camilleri M, Nelson DK, Hanson RB, Thomforde GM. Neurohormonal factors in functional dyspepsia: insights on pathophysiologic mechanisms.Gastroenterology 1991;100: 1311–1318.
Malagelada J-R, Camilleri M, Stanghellini V.Manometric Diagnosis of Gastrointestinal Motility Disorders. New York: Thieme Medical Publishers, Inc., 1986.
Camilleri M. Study of human gastroduodenojejunal motility: applied physiology in clinical practice.Dig Dis Sci 1993:38: 785–794.
Koch MB, Go VLW, DiMagno EP. Can plasma human pancreatic polypeptide be used to detect diseases of the exocrine pancreas?Mayo Clin Proc 1985;60: 259–265.
Yaksh TL, Michener SR, Bailey JE, Harty GJ, Lucas DL, Nelson DK, Roddy DR, Go VLW. Survey of distribution of substance P, vasoactive intestinal polypeptide, cholecystokinin, neurotensin, met-enkephalin, bombesin, and PHI in the spinal cord of cat, dog, sloth and monkey.Peptides 1988;9: 357–372.
Kennedy FP. Pathophysiology of pancreatic polypeptide secretion in human diabetes mellitus.Diabetes, Nutrition & Metabolism 1988;2: 155–163.
Gambardella S, Felici MG, Annibale B, Delle-Fave GF, Jacoangeli F, Spallone V, Menzinger G. Pancreatic polypeptide response to a protein-rich meal in diabetic patients with and without neuropathy.J Endocrinol Invest 1986;9: 1–4.
Lugari R, Gnudi A, Dall'Argine P, Vattini A, Rignanese G, Dall'Aglio B, Melchionda N, Colella P, Luciani A, Toscani S, Zandomeneghi R. Diabetic autonomic neuropathy and impaired human pancreatic polypeptide secretion in response to food.J Clin Endocrinol Metab 1987;64: 279–282.
Stanghellini V, Malagelada J-R. Gastric manometric abnormalities in patients with dyspeptic symptoms after fundoplication.Gut 1983;24: 790–797.
Kennedy FP, Go VLW, Cryer PE, Bolli GB, Gerich JE. Subnormal pancreatic polypeptide and epinephrine responses to insulin-induced hypoglycemia identify patients with insulin-dependent diabetes mellitus predisposed to develop overt autonomic neuropathy.Ann Intern Med 1988;108: 54–58.
Chida K, Sakamaki S, Takasu T. Alteration in autonomic function and cardiovascular regulation in amyotrophic lateral sclerosis.J Neurol 1989;236: 127–130.
Bogucki A, Salvesen R. Sympathetic iris function in amyotrophic lateral sclerosis.J Neurol 1987;234: 185–186.
Barron SA, Mazliah J, Bental E. Sympathetic cholinergic function in amyotrophic lateral sclerosis.Acta Neurol Scand 1987;75: 62–63.
Camilleri M, Malagelada J-R, Stanghellini V, Fealey RD, Sheps SG. Gastrointestinal motility disturbances in patients with orthostatic hypotension.Gastroenterology 1985;88: 1852–1859.
Sandroni P, Benarroch EE, Low PA. Pharmacologic dissection of components of the Valsalva maneuver in adrenergic failure.J Appl Physiol 1991;71: 1563–1567.
Low PA, Zimmerman BR, Dyck PJ. Comparison of distal sympathetic with vagal function in diabetic neuropathy.Muscle Nerve 1986;9: 592–596.
Low PA. Laboratory evaluation of autonomic function. In: PA Low, ed.Clinical Autonomic Disorders: Evaluation and Management. Boston, MA: Little Brown and Co., 1993: 169–196.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Camilleri, M., Balm, R.K. & Low, P.A. Autonomic dysfunction in patients with chronic intestinal pseudo-obstruction. Clinical Autonomic Research 3, 95–100 (1993). https://doi.org/10.1007/BF01818993
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01818993